Agentix (AGTX) Enterprise Value (2013 - 2026)
Agentix's (AGTX) quarterly Enterprise Value came in at -$771.0 in Q1 2026, up 82.78% YoY from -$421.82 in Q1 2025, and up 87.95% on a QoQ basis from -$6396.0 in Q4 2025.
Agentix (AGTX) Enterprise Value (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 14 years of Enterprise Value data on file, last reported at -$771.0 in Q1 2026.
- Quarterly Enterprise Value rose 82.78% year-over-year to -$771.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$771.0 (up 82.78% YoY) and the FY2026 annual result came in at -$771.0, up 82.78% from the prior year.
- Enterprise Value grew to -$771.0 in Q1 2026, from -$6396.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$189.0 in Q2 2022 to a low of -$27538.0 in Q3 2023.
- A 5-year average of -$6302.2 and a median of -$5601.0 in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value slumped 2998.41% — and 2026, when it jumped 82.78%.
- Tracing AGTX's Enterprise Value over 5 years: stood at -$679.0 in 2022, then plunged by 412.52% to -$3480.0 in 2023, then tumbled by 137.73% to -$8273.0 in 2024, then advanced by 22.69% to -$6396.0 in 2025, then jumped by 87.95% to -$771.0 in 2026.
- The last three Enterprise Value figures came in at -$771.0 (Q1 2026), -$6396.0 (Q4 2025), and -$5601.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.12 Bn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -38.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.00 |
| Mar 31, 2026 | -771.00 |
| Dec 31, 2025 | -6,396.00 |
| Sep 30, 2025 | -5,601.00 |
| Jun 30, 2025 | -4,412.00 |
| Mar 31, 2025 | -4,477.00 |
| Dec 31, 2024 | -8,273.00 |
| Sep 30, 2024 | -6,345.00 |
| Jun 30, 2024 | -9,072.00 |
| Mar 31, 2024 | -6,535.00 |
| Dec 31, 2023 | -3,480.00 |
| Sep 30, 2023 | -27,538.00 |
| Jun 30, 2023 | -5,856.00 |
| Mar 31, 2023 | -12,369.00 |
| Dec 31, 2022 | -679.00 |
| Sep 30, 2022 | -2,702.00 |
| Jun 30, 2022 | -189.00 |
| Feb 28, 2022 | -2,442.00 |
| Nov 30, 2021 | -1,237.00 |
| Aug 31, 2021 | -1,768.00 |